Previous Article | Next Article 
Journal of Clinical Microbiology, February 1998, p. 543-547, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Evaluation of the RapID CB Plus System for
Identification of Corynebacterium Species and Other
Gram-Positive Rods
Marie K.
Hudspeth,1
Sharon Hunt
Gerardo,1
Diane M.
Citron,1 and
Ellie
J. C.
Goldstein1,2,*
R. M. Alden Research Laboratory, Santa
Monica-UCLA Medical Center, Santa Monica, California
90404,1 and
UCLA School of Medicine,
Los Angeles, California 900242
Received 7 July 1997/Returned for modification 20 July
1997/Accepted 10 November 1997
 |
ABSTRACT |
Due to the difficulty of identifying Corynebacterium
spp. with standard methods, we compared them with the RapID CB
Plus system (Remel, Lenexa, Kans. [formerly Innovative Diagnostic
Systems, Norcross, Ga.]), which consists of 4 carbohydrate and 14 preformed enzyme tests, for the identification of 98 clinical isolates
of Corynebacterium sp., other coryneforms,
Listeria monocytogenes, and 17 ATCC strains. Forty (95%)
of 42 strains of Corynebacterium spp.
were accurately identified to the species level by the RapID CB Plus
system, and two additional strains of C. striatum were identified with one additional conventional test for lipid
requirement. Twenty-seven (75%) of the 36 coryneform strains
tested were identified correctly to the species level. However, three
of four strains of Brevibacterium sp. and all seven of the
L. monocytogenes strains were identified to the genus level
only. Actinomyces strains had variable results, and the one
strain of Arcanobacterium haemolyticum tested was not
identified. Overall, the RapID CB Plus system compared favorably with
the conventional methods, was easy to inoculate and interpret,
and is promising as a new method for identification of gram-positive
bacilli.
 |
INTRODUCTION |
In recent years, the incidence and
recognition of Corynebacterium species and coryneform
bacteria as etiologic agents of serious infections, such as bacterial
sepsis, endocarditis, and indwelling catheter infections, has
increased, especially in immunocompromised patients (1, 4, 11,
17). Treatment of these infections has been problematic because
of the increase in resistance to antibiotics (10, 11, 18).
Therefore, it has been suggested that susceptibility testing be
performed on isolates obtained from serious infections. Serious and
sometimes fatal clinical outcomes due to inappropriate therapy,
possibly due to the difficulty in identifying these organisms and
failure to recognize their significance, have been reported (1, 3,
4, 7, 9, 11). Because conventional methods are expensive and
time-consuming to set up, require prolonged incubation (7 to 10 days),
and have problems with overlapping biochemical reactions for different species, we evaluated a 4-h rapid identification panel, the RapID CB
Plus system (Remel, Lenexa, Kans. [formerly Innovative Diagnostic Systems, Norcross, Ga.]). We used the RapID CB Plus system, which contains substrates for 14 enzyme and 4 carbohydrate tests, to identify
Corynebacterium spp. and other gram-positive bacilli and
compared it to conventional biochemical methods.
(This study was presented in part at the 97th General meeting of the
American Society for Microbiology [poster C-459], Miami Beach, Fla.,
May 1997.)
 |
MATERIALS AND METHODS |
The following reference strains from the American Type Culture
Collection (ATCC) were studied: Actinomyces pyogenes ATCC
19411, A. bernardiae ATCC 51727, Arcanobacterium
haemolyticum ATCC 9345, Erysipelothrix rhusiopathiae
ATCC 19414, Corynebacterium pseudodiphtheriticum ATCC 10700 and 10701, Bacillus polymyxa ATCC 842, Oerskovia
xanthineolytica ATCC 27402, Brevibacterium epidermidis
ATCC 35514, C. diphtheriae ATCC 13812, C. pseudotuberculosis ATCC 19410, C. jeikeium ATCC 43734 and 43216, C. minutissimum ATCC 23348, C. striatum ATCC 6940, C. urealyticum ATCC 43042, and
C. xerosis ATCC 373. The 98 clinical isolates were as
follows: C. accolans (1 strain), C. amycolatum (4 strains), "C. aquaticum" (10 strains), C. jeikeium (11 strains), C. kutscheri (1 strain),
C. minutissimum (12 strains), C. striatum (2 strains), C. propinquum (1 strain), C. urealyticum (1 strain), Rothia sp. (2 strains),
Dermabacter hominis (2 strains), E. rhusiopathiae (2 strains), Listeria monocytogenes (7 strains), Actinomyces odontolyticus (8 strains), A. viscosus (5 strains), A. israelii (4 strains),
A. naeslundii (6 strains), Arcanobacterium haemolyticum (1 strain), Brevibacterium sp. (5 strains), Centers for Disease Control and Prevention (CDC; Atlanta,
Ga.) group F (2 strains), CDC group G (1 strain), and
Bacillus sp. (10 strains). The strains were previously
isolated from clinical specimens and identified by conventional methods
(6, 11). Isolates were obtained from various sources, as
follows: blood cultures, 11; bone, 4; cat bites, 18; dog bites, 26;
human bites, 1; other wounds, 12; abscesses, 4; urine, 2; tissue, 2;
pelvic sample, 1; respiratory samples, 2; ear, 1; appendix, 3; unknown
sources, 11. Isolates were stored in 20% skim milk at
70°C until
use. Cultures were initiated from frozen stocks. Strains of
Actinomyces were incubated in an anaerobic chamber (Anaerobe
Systems, San Jose, Calif.), subcultured twice on tryptic soy blood agar
(Hardy Diagnostics, Santa Maria, Calif.), incubated aerobically at
37°C in 5 to 7% CO2 for 24 to 48 h, and retested.
All other strains were transferred twice on tryptic soy agar with 5%
sheep blood and incubated at 37°C in 5 to 7% CO2 for 24 to 48 h.
The test inoculum for the RapID CB Plus panel (Remel) was prepared by
using a cotton-tipped swab and suspending sufficient growth in 2 ml of
inoculation fluid (provided with the kit) to produce a turbidity equal
to a no. 4 McFarland standard or 1.2 × 109 CFU/ml.
The panel was inoculated by first peeling back the upper right-hand
corner of the panel and pouring the inoculation fluid into the panel.
The panel was then tilted backward and from side to side to evenly fill
the rear baffles in the top of the panel. The panel was then tilted
forward to simultaneously inoculate all of the biochemical wells in the
front of the panel. The inoculated panel was incubated at 37°C for
4 h in ambient air.
After incubation, the first nine wells of the panel were interpreted
according to the color reactions as described by the manufacturer. Two
drops of the RapID CB Plus reagent were added to each of the five wells
that contain substrates for the aminopeptidase tests, and two drops
each of nitrate reagents A and B were added to the nitrate well. After
30 s, the reactions were interpreted (Table
1). All ATCC strains were tested at least
twice with the RapID CB Plus kit for reproducibility. Based on the
results of the RapID CB Plus kit, a profile number was generated for
each strain, which was then compared to a code compendium provided by
the manufacturer. The organisms included in the RapID CB Plus database
are listed in Table 2.
Conventional tests included both enzymatic and carbohydrate tests.
Enzymatic tests were performed by using WEE-TABS (Key Scientific Products, Co., Round Rock, Tex.). These are plastic tubes (13 by 50 mm)
that contain a tablet composed of one or more substrates. They are
inoculated with 0.5 ml of a heavy (greater than or equal to a no. 3 McFarland standard) suspension of the test organism in water and
incubated aerobically at 37°C for 2 to 4 h. The enzymes tested
with the WEE-TABS were urease, pyrazinamidase, alkaline phosphatase,
and o-nitrophenyl-
-D-galactopyranosidase.
Carbohydrate tests were chosen as specified by the CDC, except that
Andrades carbohydrates for glucose, sucrose, mannitol, and xylose
(Remel [formerly Carr Scarborough, Decatur, Ga.]) were used instead
of CDC carbohydrates, as these are commercially unavailable (6, 11, 15). The carbohydrate tests were inoculated by using a sterile stick and incubated aerobically at 37°C for 7 to 10 days. Strains that did not appear to utilize any of the carbohydrates were
supplemented with 0.1% Tween 80, as some strains are known to require
lipid supplementation for growth. Tests for hydrolysis (esculin and
gelatin), nitrate reduction, and carbohydrate fermentation of mannose,
lactose, and maltose were performed with aerated, prereduced,
anaerobically sterilized PRAS medium (Remel). In addition to tests for
carbohydrates, motility was determined by wet mount and motility media
(Hardy Diagnostics). All isolates were tested for catalase production
(by using 10% H2O2) and examined for yellow pigment production.
 |
RESULTS |
Forty (95%) of 42 strains of Corynebacterium spp. were
correctly identified by the RapID CB Plus system without supplemental tests. However, both of the C. striatum strains required an
additional test for lipid requirement (0.1% Tween) to generate a
profile number that matched the code compendium identification (Table 3). Unlike the RapID CB Plus system, the
conventional method required addition of 0.1% Tween 80 to the
carbohydrate tests for lipophilic strains. Specifically, Tween 80 was
required in the conventional carbohydrate tests of two strains of
C. jeikeium, one strain that resembled C. minutissimum, and all four strains of Brevibacterium
sp. Strains of C. amycolatum and C. striatum were difficult to identify to the species level by using the
conventional tests due to similarity of the biochemical reactions. The
only characteristics differentiating the strains of C. striatum were that the colonies were white and moist while those
of C. amycolatum were white and dry. Also, C. striatum strains were maltose negative and CAMP test positive
while C. amycolatum strains were maltose positive and CAMP
test negative.
All seven strains of L. monocytogenes were identified only
to the genus level by the RapID CB Plus system (Table
4). These seven strains were
beta-hemolytic, positive by the CAMP test with Staphylococcus
aureus, and alanyl peptide hydrolysis negative and matched the
biochemical profile of L. monocytogenes obtained by using
the conventional method.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Comparison of conventional method with RapID CB Plus
system for identification of gram-positive bacilli other than
Corynebacterium spp.
|
|
Twenty-seven (75%) of the 36 coryneforms were identified by the RapID
CB Plus system without supplemental tests (Table 4), except for one
strain of Arcanobacterium haemolyticum, which was identified
by the conventional method but not by the RapID CB Plus system. Also,
the strains of Actinomyces sp. had variable results. All
eight Actinomyces odontolyticus strains were identified correctly by the RapID CB Plus system, whereas all five A. viscosus strains were identified but required supplemental tests
for motility and pigment production because of profile numbers that
overlapped those of Oerskovia sp. Three of four A. israelii strains were identified to the species level, but one
strain produced a profile number that had no match with the code
compendium. Two of six A. naeslundii strains were identified
to the species level, while the other four strains were identified to
the genus level only. The Actinomyces sp. strains were
tested after anaerobic and aerobic incubation and showed different
results. Specifically, all strains of A. odontolyticus
were esterase and ribose positive when incubated in an anaerobic
environment and negative when incubated in CO2; also, some
strains of A. naeslundii were ribose positive, tryptophan positive, and L-glycine positive when incubated
anaerobically but were negative when incubated in a CO2
environment. The Brevibacterium strains were identified only
to the genus level by both methods, except for one strain, which the
RapID CB Plus system was able to identify as B. casei (Table
4).
Ten strains of Bacillus sp. were included in the study to
confirm that the kit will not identify strains of bacteria not included in the code compendium. The profile numbers obtained for these showed
no match. ATCC strains were all tested at least twice by using the
RapID CB Plus system, and all of the strains produced essentially the
same reactions each time, with the exception of the substrate for
phosphatase, which was variable with Bacillus polymyxa ATCC
842 and Actinomyces pyogenes ATCC 19411.
 |
DISCUSSION |
Corynebacterium spp. and other gram-positive bacilli
are difficult to identify with the existing systems. In addition,
methods such as the API Coryne system (API-BioMerieux, Inc., St. Louis, Mo.) and the conventional method have incubation periods of at least
24 h and 7 days, respectively. The long incubation period required
for biochemical tests and fastidious growth requirements for some
strains of these organisms can be a problem as well. Moreover, the
previous methods are problematic for identification of some strains of
Corynebacterium due to overlapping biochemicals or
requirement of additional tests for identification of most strains.
Therefore, the RapID CB Plus system is helpful in the identification of
these organisms because it is a 4-h test for preformed enzymes and does
not depend on growth of the organism for identification.
The RapID CB Plus system compared favorably with conventional methods
for identification of Corynebacterium sp. and most of the
other gram-positive bacilli tested. The RapID CB Plus system did not
require additional tests for the identification of most strains of
Corynebacterium spp. and other gram-positive rods, unlike
the API Coryne kit, which requires additional tests for most of these
strains (8, 13). The only strains requiring additional tests
for identification to the species level with the RapID CB Plus system
were C. striatum and A. viscosus. In addition,
the RapID CB Plus system identified several species that are difficult
to distinguish by other methods. Previous reports indicate confusion
regarding the descriptions of C. xerosis, C. striatum, and C. amycolatum (7, 11, 16),
which were based on carbohydrate fermentation. There were several
enzymatic tests that helped to identify these strains in the RapID CB
Plus system. The RapID CB Plus system percentage charts included in the
kit indicated that tests for C. amycolatum were 80% maltose
positive, 88% esterase positive, 9% L-glycine positive,
and 11% leucine positive, while those for C. striatum were
0% maltose positive, 37% esterase variable, 70%
L-glycine positive, and 82% leucine positive. The results
of these enzyme tests help to differentiate C. amycolatum
from C. striatum (8, 11, 13, 14). Other tests
previously reported to be helpful in the identification of C. amycolatum, C. striatum, and C. xerosis
include the requirement for lipids, the presence of mycolic acids,
propionic acid as a major end product of glucose metabolism, and rRNA
gene sequencing (2, 11). The latter four tests are not
suitable for clinical laboratories.
Because there is confusion regarding the taxonomy of several species of
Corynebacterium and coryneforms, the identification of some
of these strains may change in the future (7, 9, 11, 12).
For example, proper classification of "C. aquaticum" and
Aureobacterium sp. is still being considered. Therefore, we called all 10 of our strains "C. aquaticum" as their
biochemical profiles, obtained by using conventional methods, fit this
identification. Although the RapID CB Plus system also identified these
10 strains as "C. aquaticum" (Table 4),
Aureobacterium sp. is not included in the database of the
kit. A similar problem with taxonomic differentiation exists between
Brevibacterium sp. and Arthrobacterium sp. Many species of Arthrobacterium were defined based on the
biochemical reactions of single ATCC strains. We called our four
strains Brevibacterium based on the lack of clear data
regarding Arthrobacterium sp. The RapID CB Plus system
identified these strains as Brevibacterium sp., as
Arthobacterium sp. strains are also not included in the database of the kit.
The RapID CB Plus kit was designed for all strains (including strains
such as Actinomyces sp., which are often grouped with anaerobes) to be grown aerobically. We found that when strains were
incubated anaerobically, some results did not match the species profile
numbers in the code compendium. Although most of the coryneforms listed
on Table 2 were identified to the species level, some coryneform
species had erroneous results. For instance, the seven L. monocytogenes isolates were misidentified by the RapID CB Plus system as L. welshimeri because the test results were
similar for both species. Therefore, Listeria spp. can be
identified only to the genus level with this system. An improvement to
the kit to identify Listeria spp. may be to add alanyl
peptide hydrolysis as a supplemental test (5). In general,
the Actinomyces sp. strains were identified, except for some
strains that required additional tests for motility and pigmentation
(Table 4). Strains of A. naeslundii were the most difficult
to identify, as four of six could only be identified to the genus
level, one was not identified, and only one was identified to the
species level.
The conventional method using carbohydrates and some enzymatic tests is
often cumbersome, since all tests are individual tests and have to be
inoculated separately. In addition, they may require supplementation
and a long incubation period (7 to 10 days) for growth. Furthermore,
these results are sometimes difficult to achieve. A comparison of the
results obtained with the conventional method and the RapID CB Plus
system determined that these two methods had comparable results for
corynebacteria and most strains of coryneforms (Tables 3 and 4).
Because the RapID CB Plus system contains mostly substrates for
enzymatic tests, it may be more accurate than carbohydrate utilization
tests for identification of these types of organisms.
Overall, the RapID CB Plus panels compared favorably with the
conventional method, are easy to inoculate and interpret, and are
promising as a new method for identification of
Corynebacterium sp. and other gram-positive bacilli.
 |
ACKNOWLEDGMENTS |
The RapID CB Plus panels were provided by Innovative Diagnostics,
Norcross, Ga.
We thank Spencer Jang, Veterinary Medicine Teaching Hospital,
University of California at Davis, for performing whole cell wall fatty
acid analysis on some of these strains.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: R. M. Alden
Research Laboratory, 2021 Santa Monica Blvd., Suite 640E, Santa Monica, CA 90404. Phone: (310) 315-1511. Fax: (310) 315-3662.
 |
REFERENCES |
| 1.
|
Ahmed, K.,
K. Kawakami,
K. Watanabe,
H. Mitsushima,
T. Nagatake, and K. Matsumoto.
1995.
Corynebacterium pseudodiphtheriticum: a respiratory tract pathogen.
Clin. Infect. Dis.
20:41-46[Medline].
|
| 2.
|
Barreau, C.,
F. Bimet,
M. Kiredjian,
N. Rouillon, and C. Bizet.
1993.
Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin.
J. Clin. Microbiol.
31:2085-2090[Abstract/Free Full Text].
|
| 3.
|
Berner, R.,
K. Pelz,
C. Wilhelm,
A. Funke,
J. U. Leititis, and M. Brandis.
1997.
Fatal sepsis caused by Corynebacterium amycolatum in a premature infant.
J. Clin. Microbiol.
35:1011-1012[Abstract].
|
| 4.
|
Bizette, G. A.,
S. A. Kemmerly,
J. T. Cole,
H. B. Bradford, Jr., and B. H. Peltier.
1995.
Sepsis due to coryneform group A-4 in an immunocompromised host.
Clin. Infect. Dis.
21:1334-1336[Medline].
|
| 5.
|
Clark, A. G., and J. McLauchlin.
1997.
Simple color tests based on an alanyl peptidase reaction which differentiate Listeria monocytogenes from other Listeria species.
J. Clin. Microbiol.
35:2155-2156[Abstract].
|
| 6.
|
Clarridge, J. E., and C. A. Spiegel.
1995.
Corynebacterium and miscellaneous irregular gram-positive rods, Erysipelothrix, and Gardnerella, p. 357-378.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of Clinical Microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
| 7.
|
Coyle, M. B.,
R. B. Leonard,
D. J. Nowowiejski,
A. Malekniazi, and D. J. Finn.
1993.
Evidence of multiple taxa within commercially available reference strains of Corynebacterium xerosis.
J. Clin. Microbiol.
31:1788-1793[Abstract/Free Full Text].
|
| 8.
|
Freney, J.,
M. T. Duperron,
C. Courtier,
W. Hansen,
F. Allard,
J. M. Boeufgras,
D. Monget, and J. Fleurette.
1991.
Evaluation of API Coryne in comparison with conventional methods for identifying coryneform bacteria.
J. Clin. Microbiol.
29:38-41[Abstract/Free Full Text].
|
| 9.
|
Funke, G.,
P. A. Lawson,
K. A. Bernard, and M. D. Collins.
1996.
Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum.
J. Clin. Microbiol.
34:1124-1128[Abstract].
|
| 10.
|
Funke, G.,
V. Pünter, and A. Von Graevenitz.
1996.
Antimicrobial susceptibility patterns of some recently established coryneform bacteria.
Antimicrob. Agents Chemother.
40:2874-2878[Abstract].
|
| 11.
|
Funke, G.,
A. Von Graevenitz,
J. E. Clarridge III, and K. A. Bernard.
1997.
Clinical microbiology of coryneform bacteria.
Clin. Microbiol. Rev.
10:125-159[Abstract].
|
| 12.
|
Funke, G.,
A. Von Graevenitz, and N. Weiss.
1994.
Primary identification of Aureobacterium spp. isolated from clinical specimens as "Corynebacterium aquaticum."
J. Clin. Microbiol.
32:2686-2691[Abstract/Free Full Text].
|
| 13.
|
Gavin, S. E.,
R. B. Leonard,
A. M. Briselden, and M. B. Coyle.
1992.
Evaluation of the Rapid CORYNE identification system for Corynebacterium species and other coryneforms.
J. Clin. Microbiol.
30:1692-1695[Abstract/Free Full Text].
|
| 14.
|
Hollis, D. G.,
F. O. Sottnek,
W. J. Brown, and R. E. Weaver.
1980.
Use of the rapid fermentation test in determining carbohydrate reactions of fastidious bacteria in clinical laboratories.
J. Clin. Microbiol.
12:620-623[Abstract/Free Full Text].
|
| 15.
|
Hollis, D. G., and R. E. Weaver.
1983.
Gram positive organisms: a guide to presumptive identification.
Centers for Disease Control and Prevention, Atlanta, Ga.
|
| 16.
|
Martinez-Martinez, L.,
A. I. Suarez,
J. Winstanley,
M. C. Ortega, and K. Bernard.
1995.
Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples.
J. Clin. Microbiol.
33:2458-2461[Abstract].
|
| 17.
|
Sewell, D. L.,
M. B. Coyle, and G. Funke.
1995.
Prosthetic valve endocarditis caused by Corynebacterium afermentans subsp. lipophilum (CDC coryneform group ANF-1).
J. Clin. Microbiol.
33:759-761[Abstract].
|
| 18.
|
Soriano, F.,
J. Zapardiel, and E. Nieto.
1995.
Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.
Antimicrob. Agents Chemother.
39:208-214[Abstract].
|
Journal of Clinical Microbiology, February 1998, p. 543-547, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rennie, R. P., Brosnikoff, C., Turnbull, L., Reller, L. B., Mirrett, S., Janda, W., Ristow, K., Krilcich, A.
(2008). Multicenter Evaluation of the Vitek 2 Anaerobe and Corynebacterium Identification Card. J. Clin. Microbiol.
46: 2646-2651
[Abstract]
[Full Text]
-
Adderson, E. E., Boudreaux, J. W., Cummings, J. R., Pounds, S., Wilson, D. A., Procop, G. W., Hayden, R. T.
(2008). Identification of Clinical Coryneform Bacterial Isolates: Comparison of Biochemical Methods and Sequence Analysis of 16S rRNA and rpoB Genes. J. Clin. Microbiol.
46: 921-927
[Abstract]
[Full Text]
-
Renom, F., Garau, M., Rubi, M., Ramis, F., Galmes, A., Soriano, J. B.
(2007). Nosocomial Outbreak of Corynebacterium striatum Infection in Patients with Chronic Obstructive Pulmonary Disease. J. Clin. Microbiol.
45: 2064-2067
[Abstract]
[Full Text]
-
Santala, A.-M., Sarkonen, N., Hall, V., Carlson, P., Jousimies-Somer, H., Kononen, E.
(2004). Evaluation of Four Commercial Test Systems for Identification of Actinomyces and Some Closely Related Species. J. Clin. Microbiol.
42: 418-420
[Abstract]
[Full Text]
-
Goldstein, E. J. C., Citron, D. M., Merriam, C. V., Warren, Y. A., Tyrrell, K. L., Fernandez, H.
(2002). In Vitro Activities of the Des-Fluoro(6) Quinolone BMS-284756 against Aerobic and Anaerobic Pathogens Isolated from Skin and Soft Tissue Animal and Human Bite Wound Infections. Antimicrob. Agents Chemother.
46: 866-870
[Abstract]
[Full Text]
-
Goldstein, E. J. C., Citron, D. M., Merriam, C. V., Warren, Y. A., Tyrrell, K., Fernandez, H.
(2001). Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections. J Antimicrob Chemother
48: 641-651
[Abstract]
[Full Text]
-
Funke, G., Peters, K., Aravena-Roman, M.
(1998). Evaluation of the RapID CB Plus System for Identification of Coryneform Bacteria and Listeria spp.. J. Clin. Microbiol.
36: 2439-2442
[Abstract]
[Full Text]